Literature DB >> 32492301

Specialty Drugs - A Distinctly American Phenomenon.

Huseyin Naci1, Aaron S Kesselheim1.   

Abstract

Year:  2020        PMID: 32492301     DOI: 10.1056/NEJMp1909513

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.

Authors:  Robert Battat; Jonathan S Galati; Dana Lukin; Fatiha Chabouni; Robbyn Sockolow; Jeff Carter; Kristina Fajardo; Stevie Yang; Jenna Reich; Vinita Jacobs; Meira Abramowitz; Anand Kumar; Paul Christos; Randy S Longman; Robert Burakoff; Laura Simone; Tamar Sapir; Carl V Crawford; Ellen J Scherl
Journal:  J Clin Gastroenterol       Date:  2022-03-01       Impact factor: 3.062

2.  The Multiple Sclerosis Treatment Optimization Program.

Authors:  Annette Langer-Gould; Stephen C Cheng; Bonnie H Li; Michael H Kanter
Journal:  Ann Clin Transl Neurol       Date:  2021-10-18       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.